Report on trial death stokes Alzheimer's drug fears.
Where this comes from
- Record sourced from PubMed, PMID 37053319.
- Also identified by DOI 10.1126/science.adi2242.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Amyloid-clearing antibody lecanemab faces key FDA hearing in June.
Medical subject headings
- Alzheimer Disease
- Amyloid beta-Peptides
- Antibodies, Monoclonal, Humanized
- Brain